title: [Clinical evaluation of 99mTc-DTPA-HSA in patients with cerebrovascular diseases: assessment of perfusion reserve with SPECT].
authors.forename: S
authors.initials: S
authors.lastname: Nishizawa
authors.forename: N
authors.initials: N
authors.lastname: Tamaki
authors.forename: Y
authors.initials: Y
authors.lastname: Yonekura
authors.forename: T
authors.initials: T
authors.lastname: Fujita
authors.forename: J
authors.initials: J
authors.lastname: Konishi
authors.forename: M
authors.initials: M
authors.lastname: Abe
authors.forename: H
authors.initials: H
authors.lastname: Fukuyama
authors.forename: T
authors.initials: T
authors.lastname: Miyoshi
authors.forename: K
authors.initials: K
authors.lastname: Harada
authors.forename: Y
authors.initials: Y
authors.lastname: Namura
mesh_terms: D000328:Adult; D000368:Aged; D002561:Cerebrovascular Disorders / Q000000981:diagnostic imaging*; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009942:Organometallic Compounds; D004369:Pentetic Acid; D013667:Technetium; D013668:Technetium Tc 99m Aggregated Albumin; D016284:Technetium Tc 99m Pentetate; D014055:Tomography, Emission-Computed
chemical_list: D009942:Organometallic Compounds; D013668:Technetium Tc 99m Aggregated Albumin; D013667:Technetium; D004369:Pentetic Acid; D016284:Technetium Tc 99m Pentetate